Stathmin, a microtubule regulatory protein, is associated with hypoxia-inducible facto Ma levels in human endometrial and endothelial cells

Endocrinology

Volumn 150, Issue 5, 2009, Pages 2413-2418

  Yoshie, Mikihiro ^a   Miyajima, Eri ^a   Kyo, Satoru ^b   Tamura, Kazuhiro ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; REGULATOR PROTEIN; SMALL INTERFERING RNA; STATHMIN; VASCULOTROPIN; WORTMANNIN; MICROTUBULE ASSOCIATED PROTEIN; ONCOPROTEIN; STMN1 PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANGIOGENESIS; ARTICLE; CELL IMMORTALIZATION; CONTROLLED STUDY; ENDOMETRIUM CELL; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MENSTRUAL CYCLE; MICROTUBULE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGENERATION; SIGNAL TRANSDUCTION; TISSUE REPAIR; CELL CULTURE; CELL HYPOXIA; ENDOMETRIUM; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELL HYPOXIA; CELLS, CULTURED; ENDOMETRIUM; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MENSTRUAL CYCLE; MICROTUBULE-ASSOCIATED PROTEINS; ONCOGENE PROTEIN V-AKT; SIGNAL TRANSDUCTION; STATHMIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 66449099187     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-1333     Document Type: Article

References (36)

1. Critchley HO, Kelly RW, Baird DT, Brenner RM 2006 Regulation of human endometrial function: mechanisms relevant to uterine bleeding. Reprod Biol Endocrinol 4(Suppl 1):S5
2. Popovici RM, Irwin JC, Giaccia AJ, Giudice LC 1999 Hypoxia and cAMP stimulate vascular endothelial growth factor (VEGF) in human endometrial stromal cells: potential relevance to menstruation and endometrial regeneration. J Clin Endocrinol Metab 84:2245-2248
3. Punyadeera C, Thijssen VL, Tchaikovski S, Kamps R, DelvouxB, Dunselman GA,deGoeijAF, GriffioenAW, GroothuisPG2006Expressionandregulation of vascular endothelial growth factor ligands and receptors during menstruation and post-menstrual repair of human endometrium. Mol Hum Reprod 12:367-375
4. Ferrara N 2004 Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25:581-611
5. Smith SK 1998 Angiogenesis, vascular endothelial growth factor and the en- dometrium. Hum Reprod Update 4:509 -519
6. Sharkey AM, Day K, McPherson A, Malik S, Licence D, Smith SK, Charnock- Jones DS 2000 Vascular endothelial growth factor expression in human en- dometrium is regulated by hypoxia. J Clin Endocrinol Metab 85:402-409
7. Wang GL, Jiang BH, Rue EA, Semenza GL 1995 Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 92:5510-5514
8. Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS, Kaelin Jr WG 2001 HIFa targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292:464-468
9. JaakkolaP,MoleDR,TianYM,WilsonMI,GielbertJ,GaskellSJ,Kriegsheim Av, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, Ratcliffe PJ 2001 Targeting of HIF-a to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292:468 -472
10. Semenza GL 1998 Hypoxia-inducible factor 1: master regulator of O2 ho- meostasis. Curr Opin Genet Dev 8:588-594
11. CritchleyHO,OseiJ,HendersonTA,BoswellL,SalesKJ,JabbourHN,Hirani N 2006 Hypoxia-inducible factor-1a expression in human endometrium and its regulation by prostaglandin E-series prostanoid receptor 2 (EP2). Endocrinology 147:744-753
12. Tamura K, Yoshie M, Nishi H, Osakabe Y, Isaka K, Hara T, Kogo H 2006 Expression of stathmin in human uterus and decidualizing endometrial stro- mal cells. Reproduction 132:625-636
13. Curmi PA, Gavet O, Charbaut E, Ozon S, Lachkar-Colmerauer S, ManceauV, Siavoshian S, Maucuer A, Sobel A 1999 Stathmin and its phosphoprotein family: general properties, biochemical and functional interaction with tubu- lin. Cell Struct Funct 24:345-357
14. Koppel J, Boutterin MC, Doye V, Peyro-Saint-Paul H, Sobel A 1990 Devel-opmentaltissueexpressionandphylogeneticconservationofstathmin,aphos- phoprotein associated with cell regulations. J Biol Chem 265:3703-3707
15. Biechel, Maucuer A, LaurendeauI, Lachkar S, Spano AJ, Frankfurter A, Levy P, Manceau V, Sobel A, Vidaud M, Curmi PA 2003 Expression of stathmin family genes in human tissues: non-neural-restricted expression for SCLIP. Genomics 81:400-410
16. Belmont LD, Mitchison TJ 1996 Identification of a protein that interacts with tubulin dimers and increases the catastrophe rate of microtubules. Cell 84: 623-631
17. Belmont L, Mitchison T, Deacon HW 1996 Catastrophic revelations about Op18/stathmin. Trends Biochem Sci 21:197-198
18. Curmi PA, Andersen SS, Lachkar S, Gavet O, Karsenti E, Knossow M, Sobel A 1997 The stathmin/tubulin interaction in vitro. J Biol Chem 272:25029 -25036
19. Luo XN, Mookerjee B, Ferrari A, Mistry S, Atweh GF 1994 Regulation of phosphoprotein p18 in leukemic cells. Cell cycle regulated phosphorylation by p34cdc2 kinase. JBiol Chem 269:10312-10318
20. Marklund U, Osterman O, Melander H, Bergh A, Gullberg M 1994 The phenotype of a "Cdc2 kinase target site-deficient" mutant of oncoprotein 18 reveals a role of this protein in cell cycle control. J Biol Chem 269:30626-30635
21. LarssonN, MelanderH, MarklundU, OstermanO, Gullberg M1995 G2/M transitionrequiresmultisitephosphorylationofoncoprotein18 bytwodistinct protein kinase systems. J Biol Chem 270:14175-14183
22. MistrySJ, AtwehGF2001 Stathmininhibitionenhancesokadaicacid- induced mitotic arrest: a potential role for stathmin in mitotic exit. J Biol Chem 276: 31209-31215
23. Tamura K, Yoshie M, Hara T, Isaka K, Kogo H 2007 Involvement of stathmin in proliferation and differentiation of immortalized human endometrial stro- mal cells. J Reprod Dev 53:525-533
24. Kyo S, Nakamura M, Kiyono T, Maida Y, Kanaya T, Tanaka M, Yatabe N, InoueM2003 Successful immortalization ofendometrial glandular cells with normal structural and functionalcharacteristics. AmJPathol163:2259-2269
25. Mazure NM, ChenEY, LaderouteKR, Giaccia AJ 1997 Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hyp- oxia inducible factor-1 transcriptional element. Blood 90:3322-3331
26. Jiang BH, Jiang G, Zheng JZ, Lu Z, Hunter T, Vogt PK 2001 Phosphatidyl- inositol 3-kinase signaling controls levels of hypoxia-inducible factor 1. Cell Growth Differ 12:363-369
27. Guzeloglu Kayisli O, Kayisli UA, Luleci G, Arici A 2004 In vivo and in vitro regulationofAktactivationinhumanendometrialcellsisestrogendependent. Biol Reprod 71:714-721
28. Kazi AA, Koos RD 2007 Estrogen-induced activation of hypoxia-inducible factor-1a, vascular endothelial growth factor expression, and edema in the uterus are mediated by the phosphatidylinositol 3-kinase/Akt pathway. Endocrinology 148:2363-2374
29. Zhou J, SchmidT, Frank R,BruneB 2004 PI3K/Akt is required for heat shock proteins to protect hypoxia-inducible factor 1a from pVHL-independent degradation. JBiol Chem 279:13506-13513
30. Manceau V, Gavet O, Curmi P, Sobel A 1999 Stathmin interaction with HSC70 family proteins. Electrophoresis 20:409-417
31. StolarovJ, ChangK, ReinerA, Rodgers L, HannonGJ, WiglerMH, MittalV 2001 Design of a retroviral-mediated ecdysone-inducible system and its ap- plicationto theexpressionprofilingofthePTENtumor suppressor. ProcNatl Acad Sci USA 98:13043-13048
32. Saal LH, Johansson P, Holm K, Gruvberger-Saal SK, She QB, Maurer M, Koujak S, Ferrando AA, Malmstrcim P, Memeo L, Isola J, Bendahl PO, Rosen N, Hibshoosh H, Ringner M, Borg A, Parsons R 2007 Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity. Proc Natl Acad Sci USA 104:7564-7569
33. Mabjeesh NJ, Escuin D, LaVallee TM, Pribluda VS, Swartz GM, Johnson MS, Willard MT, Zhong H, Simons JW, Giannakakou P 2003 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 3:363-375
34. Escuin D, Kline ER, Giannakakou P 2005 Both microtubule- stabilizing and microtubule-destabilizing drugs inhibit hypoxia-inducible factor-1α accumulation and activity by disrupting microtubule function. Cancer Res 65:9021-9028
35. Hergovich A, Lisztwan J, Barry R, Ballschmieter P, Krek W 2003 Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL. Nat Cell Biol 5:64-70
36. Yoshie M, Kashima H, Bessho T, Takeichi M, Isaka K, Tamura K 2008 Expression of stathmin, a microtubule regulatory protein, is associated with themigrationanddifferentiation ofculturedearlytrophoblasts. Hum Reprod 23:2766-2774